Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.11 USD | +2.78% | +49.45% | -20.71% |
Apr. 26 | Foreign automakers eager for Chinese partners at Beijing auto show | RE |
Apr. 25 | Battle for 'tech luxury' in China as EVs get smarter - and cheaper | RE |
Evolution of the average Target Price on Seres Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Seres Therapeutics, Inc.
Oppenheimer | |
Chardan Research | |
Goldman Sachs | |
JPMorgan Chase | |
Canaccord Genuity | |
Piper Sandler | |
HC Wainwright | |
Chardan |
EPS Revisions
- Stock Market
- Equities
- MCRB Stock
- Consensus Seres Therapeutics, Inc.